These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23346860)

  • 21. Improving known classes of antibiotics: an optimistic approach for the future.
    Bush K
    Curr Opin Pharmacol; 2012 Oct; 12(5):527-34. PubMed ID: 22748801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antimicrobial options for the management of complicated intra-abdominal infections.
    Leone S; Damiani G; Pezone I; Kelly ME; Cascella M; Alfieri A; Pace MC; Fiore M
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):819-827. PubMed ID: 30903538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial treatment of Capnocytophaga infections.
    Jolivet-Gougeon A; Sixou JL; Tamanai-Shacoori Z; Bonnaure-Mallet M
    Int J Antimicrob Agents; 2007 Apr; 29(4):367-73. PubMed ID: 17250994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.
    Shahid M; Sobia F; Singh A; Malik A; Khan HM; Jonas D; Hawkey PM
    Crit Rev Microbiol; 2009; 35(2):81-108. PubMed ID: 19514910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
    Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
    J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP
    Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods].
    Rokosz A; Sawicka-Grzelak A; Kot K; Pituch H; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2000; 52(2):129-37. PubMed ID: 11107787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations.
    Soon RL; Lenhard JR; Bulman ZP; Holden PN; Kelchlin P; Steenbergen JN; Friedrich LV; Forrest A; Tsuji BT
    Antimicrob Agents Chemother; 2016 Apr; 60(4):1967-73. PubMed ID: 26729494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations.
    McLeod SM; Patey SA; Huband MD; Nichols WW
    Int J Antimicrob Agents; 2017 Apr; 49(4):437-442. PubMed ID: 28242258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".
    Papp-Wallace KM; Mack AR; Taracila MA; Bonomo RA
    Infect Dis Clin North Am; 2020 Dec; 34(4):773-819. PubMed ID: 33011051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?
    Wright H; Bonomo RA; Paterson DL
    Clin Microbiol Infect; 2017 Oct; 23(10):704-712. PubMed ID: 28893690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases.
    Rajer F; Allander L; Karlsson PA; Sandegren L
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0029022. PubMed ID: 35652643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®.
    Blizzard TA; Chen H; Kim S; Wu J; Bodner R; Gude C; Imbriglio J; Young K; Park YW; Ogawa A; Raghoobar S; Hairston N; Painter RE; Wisniewski D; Scapin G; Fitzgerald P; Sharma N; Lu J; Ha S; Hermes J; Hammond ML
    Bioorg Med Chem Lett; 2014 Feb; 24(3):780-5. PubMed ID: 24433862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Landscape of Diazabicyclooctane (DBO) Inhibition: Avibactam Inactivation of PER-2 β-Lactamase.
    Ruggiero M; Papp-Wallace KM; Taracila MA; Mojica MF; Bethel CR; Rudin SD; Zeiser ET; Gutkind G; Bonomo RA; Power P
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel beta-lactam antibiotics and inhibitor combinations.
    Bassetti M; Righi E; Viscoli C
    Expert Opin Investig Drugs; 2008 Mar; 17(3):285-96. PubMed ID: 18321228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New promising β-lactamase inhibitors for clinical use.
    Olsen I
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1303-8. PubMed ID: 25864193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.